How Paromomycin Works Against Protozoan Infections
Author Information
Author(s): Hobbie Sven N., Kaiser Marcel, Schmidt Sebastian, Shcherbakov Dmitri, Janusic Tanja, Brun Reto, Böttger Erik C.
Primary Institution: Institute of Medical Microbiology, University of Zurich
Hypothesis
Does paromomycin target the cytosolic or mitochondrial ribosome in protozoan parasites?
Conclusion
Paromomycin primarily affects the cytosolic ribosome of Trypanosoma, inhibiting its growth in culture and in a mouse model.
Supporting Evidence
- Paromomycin was shown to inhibit the growth of Trypanosoma in culture.
- Paromomycin increased the mean survival time of infected mice.
- The cytosolic ribosome is the preferred drug target for paromomycin.
- Paromomycin's efficacy was significantly higher against Trypanosoma than Leishmania.
- High concentrations of paromomycin did not fully eradicate the parasite.
Takeaway
Paromomycin is a medicine that helps fight certain germs in tiny creatures called protozoa, and it works best by stopping them from making proteins.
Methodology
The study involved constructing chimeric ribosomes and testing paromomycin's effects on Trypanosoma brucei in vitro and in a mouse model.
Limitations
Paromomycin did not completely eradicate the parasite in the mouse model, leading to relapse after treatment.
Participant Demographics
Female NMRI mice, 22-25 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website